Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
Company Growth (employees)
Type
Public
HQ
Cambridge, US
Founded
2010
Size (employees)
535 (est)+29%
Foundation Medicine was founded in 2010 and is headquartered in Cambridge, US

Key People at Foundation Medicine

Michael J. Pellini

Michael J. Pellini

President & CEO & Board Director
Steven J. Kafka

Steven J. Kafka

Chief Business Officer
Alexis Borisy

Alexis Borisy

Co - Founder & Chairman of the Board
Vincent A. Miller

Vincent A. Miller

SVP, Clinical Development

Foundation Medicine Office Locations

Foundation Medicine has an office in Cambridge
Cambridge, US (HQ)
150 Second St

Foundation Medicine Metrics

Foundation Medicine Financial Metrics

Revenue (2016)

$116.9 m

Revenue growth (2015-16), %

25%

Gross profit

$63.9 m

Gross profit margin (2016), %

55%

Net income (2016)

($113.2 m)

Market capitalization (21-Mar-2017)

$1.1 b

Closing share price (21-Mar-2017)

$32.5

Cash (31-Dec-2016)

$63.6 m
Foundation Medicine's current market capitalization is $1.1 b.
Foundation Medicine's revenue was reported to be $116.9 m in FY, 2016 which is a 25.4% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$29 m$61.1 m$93.2 m$116.9 m

Revenue growth, %

111%53%25%

Cost of goods sold

$11.7 m$27.4 m$36.7 m$53 m

Gross profit

$17.3 m$33.6 m$56.5 m$63.9 m

Gross profit Margin, %

60%55%61%55%

Operating expense total

$59.1 m$86.9 m$146.3 m$230.7 m

EBIT

($41.8 m)($53.3 m)($89.8 m)($113.8 m)

EBIT margin, %

(144%)(87%)(96%)(97%)

Interest expense

$235 k$42 k$124 k$624 k

Interest income

$124 k$624 k

Net Income

($42.9 m)($52.2 m)($89.6 m)($113.2 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$124.3 m$72.1 m$117.8 m$63.6 m

Accounts Receivable

$6.3 m$9.9 m

Inventories

$992 k$2.9 m$6.5 m$5.3 m

Current Assets

$133.3 m$89.6 m$229.6 m$168.9 m

PP&E

$22.1 m$21 m$41.3 m$41.5 m

Total Assets

$157.3 m$111.9 m$298 m$214 m

Accounts Payable

$7 m$7.3 m$10.5 m$11.9 m

Current Liabilities

$15.8 m$16.4 m$29.9 m$40.7 m

Additional Paid-in Capital

$221.5 m$228.2 m$489.5 m$509.7 m

Retained Earnings

($89.8 m)($142 m)($231.6 m)($344.8 m)

Total Equity

$131.7 m$86.2 m$257.7 m$164.8 m

Financial Leverage

1.2 x1.3 x1.2 x1.3 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($42.9 m)($52.2 m)($89.6 m)($113.2 m)

Depreciation and Amortization

$5 m$8.2 m$10.6 m$15.9 m

Accounts Receivable

($4.1 m)($3.6 m)$2.4 m($844 k)

Inventories

($442 k)($1.9 m)($3.7 m)$1.3 m

Accounts Payable

$1.7 m$3.1 m($1.6 m)$5.1 m

Cash From Operating Activities

($30.8 m)($42.7 m)($63.7 m)($67.2 m)

Purchases of PP&E

($6.9 m)($9.7 m)($25.4 m)($20.9 m)

Cash From Investing Activities

($8.5 m)($8.8 m)($140.7 m)$12.7 m

Interest Paid

$171 k$263 k$263 k$77 k

Foundation Medicine Market Value History

Foundation Medicine Median Salaries

Source: 15 public H-1B filings from Foundation Medicine

Foundation Medicine Online Presence

Foundation Medicine News

Foundation Medicine Company Life

You may also be interested in